<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01979432</url>
  </required_header>
  <id_info>
    <org_study_id>I11014</org_study_id>
    <nct_id>NCT01979432</nct_id>
  </id_info>
  <brief_title>The Cognitive and Cardiovascular Health in the Elderly Study</brief_title>
  <acronym>COACHES</acronym>
  <official_title>The Cognitive and Cardiovascular Health in the Elderly Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to look for the interest forecast of the IPS as
      infra-clinical cardiovascular marker in the prediction of a change of the cognitive functions
      (MCI) at the elderly of 70 and more years old without clinical cardiovascular pathology.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of patients
  </why_stopped>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">December 12, 2015</completion_date>
  <primary_completion_date type="Actual">December 12, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Incident &quot;MCI&quot; according to the following criteria</measure>
    <time_frame>one time point</time_frame>
    <description>(1) cognitive complaint (self-reported and/or informant) ; (2) preserved basic activities of daily living (ADL) ; (3) cognitive impairment (not normal for age and education) or decline in cognition evidenced by performance on objective cognitive tasks defined as a test performance &lt;1.0 standard deviations below the mean of the reference group ; (4) preserved general cognitive functioning and (5) absence of dementia.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Cognitive Diseases</condition>
  <arm_group>
    <arm_group_label>Cardiovascular evaluation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Measure of the index of systolic pressure Echo doppler Echography Measure of the speed of the wave of pulse and the central pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiovascular evaluation</intervention_name>
    <arm_group_label>Cardiovascular evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  free-living community-dwelling men and women aged ≥ 70 years,

          -  subjects free of clinical CVD related to atherosclerosis

          -  preserved basic activities of daily living (ADL = 6)

          -  without cognitive impairment (MMSE≥24)

        Exclusion Criteria:

          -  subjects with clinical history of any of the following CVD diseases : coronary artery
             disease (angina, myocardial infarction, coronary revascularization), cerebrovascular
             disease (stroke, TIA, carotid revascularization), clinical peripheral artery disease
             (claudication, critical limb ischemia)

          -  subjects with neurodegenerative, locomotor and ophtalmological diseases unable to
             perform the cognitive tests

          -  subjects unable to give written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU of Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>November 4, 2013</study_first_submitted>
  <study_first_submitted_qc>November 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2013</study_first_posted>
  <last_update_submitted>January 9, 2019</last_update_submitted>
  <last_update_submitted_qc>January 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer, cognitive diseases, Ankle-to-brachial index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

